Arcutis Biotherapeutics, Inc. (ARQT)

26.77 +0.46 (+1.75%) USD  |  NASDAQ  |  Feb 24, 12:36
More

Arcutis Biotherapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Pacira Biosciences, Inc. Upgrade